Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 4728.5 | 98 | |
N2586 | IL-17A | 100 | ng/mL | 3 | GRO-a | 16708.0 | 72 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 12751.0 | 69 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 13423.0 | 74 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 19491.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 13861.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | GRO-a | 12185.0 | 57 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | GRO-a | 4461.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 2896.0 | 71 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 2962.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 4212.5 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 4642.0 | 73 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 2585.5 | 48 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | GRO-a | 7215.0 | 69 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | GRO-a | 7984.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 6148.0 | 61 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 6150.0 | 54 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 8017.5 | 62 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 2038.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | GRO-a | 4879.0 | 60 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | GRO-a | 8827.5 | 66 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 19548.0 | 77 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 19434.0 | 47 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 18909.5 | 80 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 18043.0 | 69 |